|By PR Newswire||
|January 14, 2014 11:45 AM EST||
MANHATTAN BEACH, Calif., Jan. 14, 2014 /PRNewswire/ -- The Pancreatic Cancer Action Network welcomes Hilarie Koplow-McAdams to its National Board of Directors. Koplow-McAdams is a software industry executive from the San Francisco Bay Area, and joins the organization in honor of her father who passed away in 2012 after a nearly two year battle with pancreatic cancer.
"I watched my father battle pancreatic cancer with fortitude, living with the determination to accomplish many of his goals until his passing in May 2012," said Koplow-McAdams. "It is in the same spirit, that I join the Pancreatic Cancer Action Network to continue the fight against this devastating disease. I am honored to work with this team to reach our goal to double the survival rate for pancreatic cancer by 2020."
Hilarie Koplow-McAdams is chief revenue officer at New Relic and has previously served as salesforce.com's president of worldwide sales, in sales and product marketing leadership roles at Oracle Corporation, and as vice president of direct sales and executive committee member at Intuit.
"We are delighted to welcome Hilarie to our National Board of Directors. She brings a wealth of business knowledge and a strategic vision to the organization, and will be a valuable addition to our team as we continue to change the course of history for pancreatic cancer," stated Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network.
To learn more about the Pancreatic Cancer Action Network, visit www.pancan.org.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase the survival rate for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.
SOURCE Pancreatic Cancer Action Network